Kornitzer Capital Management’s Elevance Health ELV Stock Holding History

Kornitzer Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.48M	Buy	3,820 +290	+8%	+$108K	0.03%	361
2026 Q1	$1.03M	Hold	3,530	–	–	0.02%	388
2025 Q4	$1.24M	Buy	3,530 +10	+0.3%	+$3.38K	0.03%	373
2025 Q3	$1.14M	Buy	3,520 +5	+0.1%	+$1.55K	0.02%	387
2025 Q2	$1.37M	Buy	3,515 +5	+0.1%	+$2.01K	0.03%	353
2025 Q1	$1.53M	Buy	3,510 +110	+3%	+$44.2K	0.03%	339
2024 Q4	$1.25M	Sell	3,400 -95	-3%	-$39.8K	0.02%	365
2024 Q3	$1.82M	Hold	3,495	–	–	0.03%	336
2024 Q2	$1.89M	Buy	3,495 +120	+4%	+$63.4K	0.04%	341
2024 Q1	$1.75M	Sell	3,375 -54	-2%	-$26.9K	0.03%	352
2023 Q4	$1.62M	Hold	3,429	–	–	0.03%	346
2023 Q3	$1.49M	Buy	3,429 +50	+1%	+$22.7K	0.03%	351
2023 Q2	$1.5M	Buy	3,379 +4	+0.1%	+$1.84K	0.03%	362
2023 Q1	$1.55M	Hold	3,375	–	–	0.03%	349
2022 Q4	$1.73M	Hold	3,375	–	–	0.04%	341
2022 Q3	$1.53M	Hold	3,375	–	–	0.03%	352
2022 Q2	$1.63M	Hold	3,375	–	–	0.03%	359
2022 Q1	$1.66M	Hold	3,375	–	–	0.03%	368
2021 Q4	$1.56M	Hold	3,375	–	–	0.02%	397
2021 Q3	$1.26M	Hold	3,375	–	–	0.02%	420
2021 Q2	$1.29M	Hold	3,375	–	–	0.02%	421
2021 Q1	$1.21M	Hold	3,375	–	–	0.02%	413
2020 Q4	$1.08M	Hold	3,375	–	–	0.02%	417
2020 Q3	$906K	Hold	3,375	–	–	0.02%	410
2020 Q2	$888K	Hold	3,375	–	–	0.02%	414
2020 Q1	$766K	Hold	3,375	–	–	0.02%	408
2019 Q4	$1.02M	Hold	3,375	–	–	0.02%	407
2019 Q3	$810K	Hold	3,375	–	–	0.01%	412
2019 Q2	$952K	Sell	3,375 -900	-21%	-$246K	0.02%	404
2019 Q1	$1.23M	Hold	4,275	–	–	0.02%	360
2018 Q4	$1.12M	Hold	4,275	–	–	0.02%	365
2018 Q3	$1.17M	Hold	4,275	–	–	0.02%	375
2018 Q2	$1.02M	Hold	4,275	–	–	0.02%	375
2018 Q1	$939K	Hold	4,275	–	–	0.02%	386
2017 Q4	$962K	Hold	4,275	–	–	0.02%	390
2017 Q3	$812K	Hold	4,275	–	–	0.01%	395
2017 Q2	$804K	Hold	4,275	–	–	0.01%	400
2017 Q1	$707K	Buy	4,275 +1,800	+73%	+$286K	0.01%	401
2016 Q4	$356K	Buy	2,475 +250	+11%	+$33.5K	0.01%	441
2016 Q3	$279K	Hold	2,225	–	–	0.01%	436
2016 Q2	$292K	Sell	2,225 -100	-4%	-$13.7K	0.01%	426
2016 Q1	$323K	Hold	2,325	–	–	0.01%	418
2015 Q4	$324K	Buy	2,325 +75	+3%	+$10.3K	0.01%	419
2015 Q3	$315K	Buy	2,250 +100	+5%	+$15K	0.01%	412
2015 Q2	$353K	Sell	2,150 -150	-7%	-$24K	﹤0.01%	413
2015 Q1	$355K	Buy	+2,300	New	+$327K	﹤0.01%	406

Other funds holding ELV

AACR

ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return

HGIM

High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Focused Investors Los Angeles, California $2.96B AUM 15.6% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Kornitzer Capital Management's ELV Position: Q2 2026 in Review

Kornitzer Capital Management increased its Elevance Health (ELV) stake by 8.2% in Q2 2026, buying an estimated $108K and bringing the position to 3,820 shares worth $1.48M. The position accounts for 0.03% of the portfolio, ranked #361.

Kornitzer Capital Management first reported a position in ELV in Q1 2015 and has held it in 46 quarters since. The position peaked at $1.89M in Q2 2024. 637 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Kornitzer Capital Management held 3,820 shares of Elevance Health worth $1.48M as of Q2 2026.
Kornitzer Capital Management bought 290 Elevance Health shares in Q2 2026, an estimated $108K.
Elevance Health made up 0.03% of Kornitzer Capital Management's portfolio in Q2 2026, its #361 holding.
Kornitzer Capital Management first reported a position in Elevance Health in Q1 2015 and has held it in 46 quarters since.
Kornitzer Capital Management's Elevance Health position peaked at $1.89M in Q2 2024.
637 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Kornitzer Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.